Chan MWY - Search Results

1

Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model.

Lu CC, Shen CH, Chang CB, Hsieh HY, Wu JD, Tseng LH, Hwang DW, Chen SY, Wu SF, Chan MWY, Hsu CD. Lu CC, et al. Among authors: chan mwy. Mol Med. 2016 Sep;22:64-73. doi: 10.2119/molmed.2015.00085. Epub 2016 Jan 13. Mol Med. 2016. PMID: 26837068 Free PMC article.

2

Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.

Chen PC, Tsai MH, Yip SK, Jou YC, Ng CF, Chen Y, Wang X, Huang W, Tung CL, Chen GC, Huang MM, Tong JH, Song EJ, Chang DC, Hsu CD, To KF, Shen CH, Chan MW. Chen PC, et al. BMC Med Genomics. 2011 May 20;4:45. doi: 10.1186/1755-8794-4-45. BMC Med Genomics. 2011. PMID: 21599969 Free PMC article.

3

Analysis of DNA methylation in human BK virus.

Chang CF, Wang M, Fang CY, Chen PL, Wu SF, Chan MW, Chang D. Chang CF, et al. Virus Genes. 2011 Oct;43(2):201-7. doi: 10.1007/s11262-011-0627-3. Epub 2011 May 31. Virus Genes. 2011. PMID: 21626299

4

The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan.

Shen CH, Wu JD, Hsu CD, Jou YC, Lin CT, Wang M, Wu SF, Chan MW, Chiang MK, Fang CY, Chang D. Shen CH, et al. J Med Virol. 2011 Dec;83(12):2191-9. doi: 10.1002/jmv.22240. J Med Virol. 2011. PMID: 22012728

5

High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma.

Shen CH, Hsieh HY, Wang YH, Chen SY, Tung CL, Wu JD, Lin CT, Chan MW, Hsu CD, Chang D. Shen CH, et al. Exp Ther Med. 2010 Sep;1(5):893-898. doi: 10.3892/etm.2010.134. Epub 2010 Jul 21. Exp Ther Med. 2010. PMID: 22993615 Free PMC article.

6

The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Lu CC, Lin MY, Chen SY, Shen CH, Chen LG, Hsieh HY, Chan MW, Hsu CD. Lu CC, et al. BMC Complement Altern Med. 2013 Feb 23;13:44. doi: 10.1186/1472-6882-13-44. BMC Complement Altern Med. 2013. PMID: 23433042 Free PMC article.

7

SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin.

Tseng KC, Chou JL, Huang HB, Tseng CW, Wu SF, Chan MW. Tseng KC, et al. J Clin Immunol. 2013 Aug;33(6):1110-6. doi: 10.1007/s10875-013-9903-4. Epub 2013 May 24. J Clin Immunol. 2013. PMID: 23702664

8

Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.

Chan MW, Chang CB, Tung CH, Sun J, Suen JL, Wu SF. Chan MW, et al. Mol Med. 2014 Jun 26;20(1):248-56. doi: 10.2119/molmed.2013.00159. Mol Med. 2014. PMID: 24869907 Free PMC article.

9

DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.

Lin HY, Hung SK, Lee MS, Chiou WY, Huang TT, Tseng CE, Shih LY, Lin RI, Lin JM, Lai YH, Chang CB, Hsu FC, Chen LC, Tsai SJ, Su YC, Li SC, Lai HC, Hsu WL, Liu DW, Tai CK, Wu SF, Chan MW. Lin HY, et al. Oncotarget. 2015 Jan 20;6(2):915-34. doi: 10.18632/oncotarget.2821. Oncotarget. 2015. PMID: 25460508 Free PMC article.

10

Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients.

Chou JL, Huang RL, Shay J, Chen LY, Lin SJ, Yan PS, Chao WT, Lai YH, Lai YL, Chao TK, Lee CI, Tai CK, Wu SF, Nephew KP, Huang TH, Lai HC, Chan MW. Chou JL, et al. Clin Epigenetics. 2015 Jan 14;7(1):1. doi: 10.1186/s13148-014-0036-2. eCollection 2015. Clin Epigenetics. 2015. PMID: 25628764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page